EUVIMEDEUVIMED entdecken
Crossref

Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients

You Zheng iD, Baohua Xu, Shengyang Chen, Maobai Liu, Huiping Huang iD, Jingting Wang, Xuemei Wu iD

The Journal of Clinical Pharmacology · 2023

DOI: 10.1002/jcph.2261 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Pharmacology, 2023. Verfasst von You Zheng und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Polymyxin B, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A population pharmacokinetic (pop PK) model of polymyxin B was developed using nonlinear mixed‐effects (NONMEM) modeling based on free plasma concentrations to determine whether dose adjustment is required in critically ill patients. One thousand pharmacokinetic profiles for virtual patients with a body weight of 70 kg were simulated using Monte Carlo simulation at different dose scenarios, and area under the concentration–time curve of free drug (fAUC) was computed. The probability of target attainment (PTA) at each minimum inhibitory concentration (MIC) was calculated using fAUC/MIC as a pharmacokinetic/pharmacodynamic (PK/PD) index. The final population PK model was a 2‐compartment model. PTA showed that 3.5 mg/kg/day regimens of polymyxin B effectively achieved the fAUC/MIC target of 10 (one log 10 kill) against Pseudomonas aeruginosa strains with MIC of 1 mg/L or less (PTA, 90.7% or greater), while the dose regimen were ineffective against strains with an MIC of 2 mg/L or greater (PTA, 56.9% or less). For Klebsiella pneumoniae , the fAUC/MIC target of 17.4 (one log 10 kill) was achieved in more than 90.4% of cases for MIC of 0.5 mg/L or less with 3 mg/kg/day regimens. However, the PTA decreased dramatically as MICs increased above 1 mg/L (PTA, 56.1% or less). The polymyxin B dosage regimen of 3.5 mg/kg/day and 3 mg/kg/day are sufficient to treat P. aeruginosa infections with an MIC of 1 mg/L or less and K. pneumoniae infections with an MIC of 0.5 mg/L or less, respectively. The current recommended dose (1.5–3 mg/kg/day) of polymyxin B appears inadequate to attain the PK/PD target for therapeutic efficacy against infections caused by P. aeruginosa and K. pneumoniae isolates when MIC is above the values.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polymyxin BAnti-Bacterial AgentsHumansMonte Carlo MethodCritical IllnessComputer SimulationMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Monte Carlo simulationpharmacokinetic/pharmacodynamic (PK/PD) indexpolymyxin Bpopulation pharmacokineticsprobability of target attainment

Substanzen

Polymyxin BAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • School of Pharmacy, Fujian Medical University, Fuzhou, Fujian, China.
  • College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA.

ORCID-Profile: You Zheng, Huiping Huang, Xuemei Wu

Zitieren

APA

Zheng, Y., Xu, B., Chen, S., Liu, M., Huang, H., Wang, J., & Wu, X. (2023). Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients. The Journal of Clinical Pharmacology. https://doi.org/10.1002/jcph.2261

Vancouver

Zheng Y, Xu B, Chen S, Liu M, Huang H, Wang J, et al. Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients. The Journal of Clinical Pharmacology. 2023. doi:10.1002/jcph.2261

BibTeX
@article{Zheng2023,
  author = {Zheng, You and Xu, Baohua and Chen, Shengyang and Liu, Maobai and Huang, Huiping and Wang, Jingting and Wu, Xuemei},
  title = {Population Pharmacokinetic Modeling Using Polymyxin B Free Plasma Concentrations From Published Reports and Evaluation of Dosage Regimens Based on Monte Carlo Simulation in Critically Ill Patients},
  journal = {The Journal of Clinical Pharmacology},
  year = {2023},
  doi = {10.1002/jcph.2261}
}
Kostenlos starten →